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 The corneal endothelium is a single layer of cells lining
the posterior surface of the cornea, and it helps maintain cor-
neal transparency by regulating the hydration of the corneal
stroma. It is widely accepted that corneal endothelial cells do
not proliferate in humans once the endothelial monolayer is
formed [1]. It is also known that the density of human corneal
endothelial cells (HCECs) decreases by approximately 0.5%
per year throughout life, and that the enlargement of the re-
maining cells compensates for this reduction to maintain cor-
neal endothelial function [1-4]. In addition, a variety of inju-
ries such as surgical stress during intraocular surgery, corneal
trauma, and viral infections often cause an extensive reduc-
tion in the number of corneal endothelial cells, which can re-
sult in corneal endothelial dysfunction known as bullous
keratopathy. Although penetrating keratoplasty (PKP) and
other modern surgical procedures, including deep lamellar
endothelial keratoplasty (DLEK), stripping and automated
endothelial keratoplasty (DSAEK), can restore vision in such
patients, it would be more beneficial to regulate the prolifera-
tion of corneal endothelial cells by manipulating cell cycles.
It has been demonstrated that HCECs are arrested in the
G1 phase of the cell cycle in vivo rather than resting in the G0
phase [5]. In fact, HCECs have been shown to possess a strong
potential to proliferate depending upon the age they are cul-
tured [6]. Among the anti-mitotic factors associated with the
G1 arrest of the HCECs, transforming growth factor-β2 (TGF-
β2) is known to block the G1-S transition by blocking the phos-
phorylation of p27kip1, which is required for the nuclear export
of the inhibitory molecules for degradation [7,8]. The mecha-
nisms involved in the cell cycling and proliferation of HCECs
however have not been fully determined as yet.
In searching for a cell cycling mechanism, we focused on
DNA binding transcriptional factors, including the members
of the BTB/POZ-zinc finger protein family. The BTB/POZ-
zinc finger proteins are sequence-specific transcriptional re-
pressors characterized by a BTB/POZ domain, which is re-
sponsible for transcriptional repression, and a zinc finger do-
main that forms the DNA binding domain [9]. Among the fam-
ily members, the PLZF gene was first identified by its fusion
to the retinoid acid receptor (RAR) alpha locus in a therapy-
resistant form of acute promyelocytic leukemia associated with
the t(11;17) translocation [10]. PLZF is a sequence-specific
DNA binding transcriptional repressor that suppresses the tran-
scription of genes such as cyclin A2 and c-myc [11-13]. In
addition to these genes, it has been reported that pre-B-cell
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Purpose: To determine whether the promyelocytic leukemia zinc finger (PLZF) protein, a transcriptional repressor and
negative regulator during cell cycling, plays a role in the proliferation of cultured human corneal endothelial cells (HCECs).
Methods: The expressions of the mRNA and the protein of PLZF were determined by real-time PCR and western blot
analysis, respectively. The changes in the expression of the PLZF gene of cultured HCECs were investigated at different
times after cell-cell contacts were disrupted by incubation with EDTA. The cell proliferation rate was assessed with a real-
time cell electronic sensing (RT-CES) system after cultured HCECs were infected with either PLZF or LacZ encoding
adenovirus vector (Ad-PLZF or Ad-LacZ). The PLZF-regulating genes were analyzed by DNA microarray analysis in
cultured HCECs infected with Ad-PLZF.
Results: The expression of the mRNA of PLZF was first detected when the cultured HCECs became confluent, and the
relative amount of PLZF mRNA continued to increase for up to 5 days as the cell-cell contacts were formed more firmly.
On the other hand, the expression of the mRNA of PLZF decreased about 20 fold 3 h after EDTA exposure, and gradually
returned to the original level as the cell-cell contacts were reformed at 72 h after the exposure. The assessment using the
RT-CES system showed that the proliferation of cultured HCECs was inhibited for up to 72 h when infected by Ad-PLZF.
DNA microarray analysis revealed that the transforming growth factor-β stimulated clone 22 (TSC-22) gene was up-
regulated by 2.32 fold when infected by Ad-PLZF.
Conclusions: These findings indicate that the expression of PLZF in HCECs is closely related to the formation of cell-cell
contacts, and that PLZF may play a role in suppressing their proliferation.
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649leukemia transcription factor 1 (Pbx1) can be a target gene for
PLZF to suppress melanoma cell growth [14].
In preliminary experiments, we investigated the expres-
sion pattern of several members of the BTB/POZ-zinc finger
protein family that were considered to be negative regulators
in the cycling of HCECs. Interestingly, the expression level of
the mRNA of PLZF alone was found to vary according to the
state of the cell-cell contact. Thus, the purpose of this study is
to investigate the sequential changes in the expression of the
mRNA of PLZF in HCECs in the primary culture and after
EDTA exposure. In addition, we examined what role PLZF
plays in the proliferation of HCECs using an adenovirus vec-
tor carrying genes encoding PLZF.
METHODS
Media and culture conditions:  All primary and passaged
HCECs were cultured in a media consisting of Dulbecco modi-
fied Eagle medium (DMEM) supplemented with 15% fetal
bovine serum (FBS), 30 mg/l of L-glutamine, 2.5 mg/l of
Fungizone (GIBCO, Grand Island, NY), 2.5 mg/l of doxycy-
cline (Sigma-Aldrich Co., St.Louis, MO), and 2 µg/ml of ba-
sic fibroblast growth factor (Invitrogen, Carlsbad, CA) [15].
Cultured HCECs were maintained in a humidified incubator
at 37 °C and 10% CO2.
Primary cultures of human corneal endothelial cells:  All
procedures including those on human subjects were conducted
in accordance with the principles of the Declaration of Helsinki
[16], and this study was approved by the Institutional Review
Board of Ehime University.
Primary cultures of HCECs were started from normal
human corneas acquired from the American Eye Bank. Hu-
man tissue was used in strict accordance with the tenets of the
Declaration of Helsinki. The corneoscleral buttons were stored
in Optisol (Chiron, Irvine, CA) at 4 °C and were cultured within
10 days of enucleation. Small explants from the endothelial
layer, including Descemet’s membrane, were removed with
sterile surgical forceps and cultured in 35 mm culture dishes
coated with mouse collagen type IV (BD Biosciences, San
Jose, CA).
When a sufficient density of proliferating cells was at-
tained, the cultured HCECs were rinsed three times in Ca2+-
and Mg2+-free phosphate-buffered saline (PBS-), trypsinized
for 2 min at 37 °C, and passaged at ratios ranging from 1:1 to
1:4, depending on the number of proliferating colonies [15].
All subsequent passages were carried out using the same
method, but at a ratio of 1:6. The approximate time to
confluence after each passaging was 6 to 8 days. We used cul-
tured human corneal endothelial cells at the fifth passage for
the experiments.
RNA extraction and RT-PCR:  Total RNA was isolated
from HCECs and cultured HCECs using TRIzol reagent ac-
cording to the manufacturer’s instructions (Invitrogen). They
were further purified by RNeasy kit (Qiagen, Valencia, CA).
cDNA was synthesized with Superscript II reverse transcriptase
according to the manufacturer’s instructions (Invitrogen).
PCR amplification was performed with TaKaRa Ex Taq
(TaKaRa, Kusatsu, Japan) under the following conditions: 94
°C for 5 min, 35 or 40 cycles of denaturation at 94 °C for 10 s,
annealing at 60 °C, except for Kaiso (62 °C for Kaiso), for 20
s, and extension at 72 °C for 30 s. The primer pairs used for
RT-PCR are listed in Table 1.
Real-time polymerase chain reaction:  Real-time PCR was
performed with the DyNAmo STBR Green qPCR kit
(Finnzymes, Espoo, Finland) under the following conditions:
95 °C for 15 min, 40 cycles of denaturation at 95 °C for 10 s,
annealing at 60 °C for 20 s, and extension at 72 °C for 30 s
using the Opticon2 DNA Engine (Bio Rad, Hercules, CA).
The primer pairs used for real time PCR are listed in Table 2.
The Ct values were determined by Opticon2 software, and the
amount of each mRNA was calculated relative to the amount
of GAPDH mRNA in the same samples [17]. Each run was
completed with a melting curve analysis to confirm the speci-
ficity of the amplification and the absence of primer dimers.
Releasing model of cell-cell contacts:  To examine the
effect of cell-cell contact on the expression of the PLZF gene,
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TABLE 1. SEQUENCES OF PRIMERS USED IN RT-PCR
                                            Product    GenBank
  Primer           Sequence (5'-3')          size      number
-----------   ---------------------------   -------   ---------
GAPDH         F1-CGTATTGGGCGCCTGGTCACCAG    294 bp    AY340484
GAPDH         R1-TCACTCCTGGAAGATGGTGATGGG
PLZF          F1-CCACCCCTACGAGTGTGAGT       181 bp    NM_006006
PLZF          R1-CTCAAAGGGCTTCTCACCTG
BCL-6         F1-GATGAGATTGCCCTGCATTT       203 bp    NM_138931
BCL-6         R1-TTCTTCCAGTTGCAGGCTTT
Kaiso         F1-ACCTGTGCAGGAATTTCCAC       221 bp    AY302699
Kaiso         R1-GAGCGGCCAAGTTACTGAAG
MYNN          F1-AGGCCAAGCCAATGTGTAAC       248 bp    AY514901
MYNN          R1-ATGATGCATGCGACTATGGA
KIAA0441      F1-CTTGTTGGGGATCAAGAGGA       214 bp    NM_014797
KIAA0441      R1-GGACCTGTAGCGAGTGCTTC
ZNF278        F1-AAGCAGGTGGCTTGTGAGAT       174 bp    NM_032052
ZNF278        R1-CCACAGCTCTGGCAGATGTA
E-cadherin    F1-TGCCCAGAAAATGAAAAGG        200 bp    NM_004360
E-cadherin    R1-GTGTATGTGGCAATGCGTTC
N-cadherin    F1-GACAATGCCCCTCAAGTGTT       179 bp    NM_001792
N-cadherin    R1-CCATTAAGCCGAGTGATGGT
VE-cadherin   F1-CCTACCAGCCCAAAGTGTGT       249 bp    NM_001795
VE-cadherin   R1-GACTTGGCATCCCATTGTCT
V-cadherin    F1-TGATGATGCCAAAAACCTCA       198 bp    NM_001257
V-cadherin    R1-ATGGGCAGGTTGTAGTTTGC
P-cadherin    F1-AACCTCCACAGCCACCATAG       181 bp    NM_001793
P-cadherin    R1-GTCTCTCAGGATGCGGTAGC
In the table, GAPDH=glyceral-dehyde-3-phosphate dehydrogenase,
PLZF=promyelocytic leukemia zinc finger, and BCL-6 =B-cell lym-
phoma 6.
TABLE 2. SEQUENCES OF PRIMERS USED IN REAL-TIME PCR
                                       Product    GenBank
  Primer        Sequence (5'-3')        size      number
----------   -----------------------   -------   ---------
GAPDH        F2-CGACCACTTTGTCAAGCTCA   228 bp    AY340484
GAPDH        R2-AGGGGTCTACATGGCAACTG
PLZF         F2-GGTCGAGCTTCCTGATAACG   237 bp    NM_006006
PLZF         R2-GCCATGTCAGTGCCAGTATG
TSC-22       F1-GCTGCCGTTTTCTGTTTCTC   152 bp    AF256226
TSC-22       R1-ATCCATCGCCACTGGTCTAC
N-cadherin   F1-GACAATGCCCCTCAAGTGTT   179 bp    NM_001792
N-cadherin   R1-CCATTAAGCCGAGTGATGGT
ZO-1         F1-TGAGGCAGCTCACATAATGC   224 bp    NM_003257
ZO-1         R1-GGTCTCTGCTGGCTTGTTTC
In the table, TSC-22=transforming growth factor-β stimulated clone
22.
650we first determined the effective concentration of EDTA that
altered the integrity of endothelial cell-cell contact. Cultured
HCECs were incubated for 2 h in 2.7, 3.2, and 4.0 mM of di-
sodium EDTA.2H2O (EDTA). EDTA was prepared in DMEM
with 15% FBS. Exposure to 2.7 mM of EDTA for 2 h caused
a mild lateral separation of the cells, and incubation in 3.2
mM EDTA for 2 h caused a moderate lateral separation of the
cells. Incubation in 4.0 mM of EDTA for 2 h caused a marked
lateral separation and loss of contact to the dish. When 3.2
mM EDTA was used for 2 h to disrupt the cell-cell contacts of
HCECs, the lateral separation of the cells was reversed by
replacing the EDTA-rich media with normal culture medium.
Therefore, we decided to use 3.2 mM EDTA for 2 h as the
condition to disrupt the cell-cell contacts.
HCECs were cultured until confluent, and then the me-
dium was replaced by one containing 3.2 mM EDTA. Cul-
tured HCECs were treated with EDTA for 2 h and returned to
the normal culture medium for up to 72 h. Cultured HCECs
were collected at 1, 3, 6, 24, and 72 h after returning the cells
to the normal culture medium, and the relative amounts of the
mRNA of PLZF were evaluated by real-time PCR.
Adenovirus vector construction and infection into cultured
human corneal endothelial cells:  The degree of infection by
GFP-expressing adenovirus vector (Ad-GFP) of the cultured
HCECs was determined by counting the number of GFP posi-
tive cells when infected at a multiplicity of infection (MOI) of
50, 100, and 200. Adenovirus vector carrying genes encoding
PLZF (Ad-PLZF) or LacZ (Ad-LacZ) were prepared using an
adenovirus expression vector kit (Takara Biomedicals) as de-
scribed [14,18]. Purified, concentrated, and titer-checked vi-
ruses were used for the infections.
Western blot analysis:  HCECs in culture dishes were
rinsed two times with PBS- and then lysed with Laemmli
sample buffer (Bio-Rad, Hercules, CA) with β-
mercaptoethanol, and the final concentration was 5%. Equiva-
lent volumes of samples were separated on 7.5% polyacryla-
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Figure 1. Expression of the mRNA of BTB/POZ-zinc finger-con-
taining transcription factors by RT-PCR.  A: Ethidium-bromide-
stained agarose gels showing PCR products for PLZF, BCL-6, Kaiso,
myoneurin, KIAA0441, ZNF278, and GAPDH. Similar results were
obtained in two other experiments (35 cycles). Lane 1: Sub-confluent
cultured HCECs; Lane 2: 100% confluent cultured HCECs; Lane 3:
in vivo normal HCECs. B: Ethidium-bromide-stained agarose gels
showing PCR products for PLZF in vivo normal human corneas,
ages: 5, 59, 62, 67, and 73 years (40 cycles).
Figure 2. Kinetics of mRNA of PLZF in primary cultured HCECs.
A: Cell number in 6 well plates for each condition. B: Time course of
the expression of PLZF mRNA in cultured HCECs. Cultured HCECs
were collected at 40%, 60%, 80%, and 100% (1 day, 3 days, 5 days,
and 7 days after reached confluency). The relative expression of PLZF
mRNA was determined by real-time PCR, and the amount of each
mRNA was calculated relative to the amount of GAPDH mRNA in
the same sample (n=3 each). The ratio of the sample from 100%/1
day was set to “1”. C: Ethidium-bromide-stained agarose gels show-
ing PCR (40 cycles) products for PLZF and GAPDH.
651mide gel containing sodium dodecyl sulfate (SDS-PAGE) and
transferred to polyvinylidene (PVDF) membranes. After block-
ing with 5% nonfat dry milk and 0.1% Tween-20 in PBS, the
membrane was incubated with monoclonal anti-human PLZF
antibody (Oncogene Research Products, Cambridge, MA) for
1 h. The positive immunoreactions were made visible by the
ECL plus detection system according to the manufacturer’s
instructions (Amersham Pharmacia Biotech, Piscataway, NJ).
In vitro cell proliferation:  The rate of cellular prolifera-
tion was analyzed with a real-time cell electronic sensing (RT-
CES) system (ACEA Bioscience, San Diego, CA). Cells were
grown on the surfaces of microelectronic sensors, which are
composed of a circle-on-line electrode arrays and are inte-
grated into the bottom surfaces of the microtiter plate. Changes
in cell number were monitored and quantified by detecting
sensor electrical impedance. For cell quantification and vi-
ability measurements, the data generated on the RT-CES sys-
tem correlated well with those from the colorimetric (MTT)
assay. Cell index (CI) values obtained on the RT-CES system
were quantitatively correlated with the cell numbers [19,20].
The cells were harvested 24 h after infection with Ad-
PLZF or Ad-LacZ at an MOI of 100 and seeded into a 16-well
strip at a density of 1x104 cells/well. The sensor devices were
placed into the 5% CO2 incubator, and the cell index value
was determined every hour automatically by the RT-CES sys-
tem for up to 72 h.
Microarray analyses:  Cultured HCECs of 50%
confluency were infected with Ad-PLZF or Ad-LacZ at an
MOI of 100. Total RNA was isolated from Ad-PLZF or Ad-
LacZ infected HCECs at 48 h post-infection. The Acegene
Human oligo chip 30K (Hitachi Software Engineering,
Yokohama, Japan) containing 30,000 genes was used to com-
pare gene expression in cultured HCECs infected with Ad-
PLZF or Ad-LacZ. Initial data analysis for each chip was per-
formed using DNASIS-Array software (Hitachi Software En-
gineering, Japan).
Statistical analyses:    Values are presented as
means±standard deviations. Differences between the groups
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Figure 3. Effect of disruption of the cell-cell contact on PLZF mRNA
expression.  A: Effect of 3.2 mM of EDTA on the integrity of human
corneal endothelial cell-cell contact. 1: No treatment: cell-cell con-
tact is intact. 2: Incubation with EDTA for 2 h leads to moderate cell-
cell separation. 3: Incubation in medium without EDTA for 24 h af-
ter incubation with EDTA for 2 h. Cell-cell contact has recovered. B:
HCECs were cultured until confluent, the medium was then replaced
by medium containing 3.2 mM EDTA for 2 h, and returned to the
normal culture medium for 72 h. The relative expression of PLZF
mRNA was determined by real-time PCR, and the amount of mRNA
was calculated relative to the amount of GAPDH mRNA in the same
sample. The ratio of the sample from 3 h post-incubation was set to
1. This experiment was repeated twice. C: The same experiment was
performed on cultured human umbilical vein endothelial cells. The
ratio of the sample from subconfluent culture was set to 1.
652were analyzed with unpaired Student’s t tests. All t tests were
two-side, and a p value of <0.05 was considered to be statisti-
cally significant.
RESULTS
Comparison of mRNA expression of BTB/POZ-zinc finger-
containing transcription factors in confluent and subconfluent
cultured HCECs in vitro and normal HCECs in vivo:  The
expression of six human BTB/POZ-Zinc finger-containing
transcription factors: promyelocytic leukemia zinc finger
(PLZF), B-cell lymphoma 6 (BCL-6), Kaiso, myoneurin,
KIAA0441, and zinc finger protein278 (ZNF278), were com-
pared in confluent and subconfluent cultured HCECs by RT-
PCR. The gene with a different expression pattern might be
considered to be a good candidate for regulating the prolifera-
tion of HCECs. The results showed that the mRNA of PLZF
was expressed only when HCECs were confluent and the ex-
pression of the mRNA of the other transcription factors was
unchanged in both confluent and subconfluent HCECs. The
mRNA of PLZF was also undetectable by RT-PCR up to 40
cycles in subconfluent cultured HCECs (Figure 1A). These
results were consistent with the findings in all HCECs from
different human donors. The mRNA of PLZF was also found
to be expressed in the corneal endothelial cells obtained from
normal human corneas (ages: 5, 59, 62, 67, and 73 years; Fig-
ure 1B).
Kinetics of PLZF mRNA expression in primary cultured
HCEC:  Next, the kinetics of the PLZF mRNA expression in
primary cultured HCECs was examined by real-time PCR.
The mRNA of PLZF was not expressed when HCECs were
still in the proliferation phase but began to be expressed at the
100% confluency (1 day) which seemed to occur when they
reached confluency (Figure 2B). The mRNA of PLZF was
undetectable by RT-PCR up to 40 cycles in cultured HCECs
of 40%, 60%, and 80% confluency (Figure 2C). After reach-
ing confluency, the relative expression level of PLZF mRNA
continued to increase for up to 5 days (Figure 2A-C). Cell-
cell contacts were still not formed in the proliferation phase,
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Figure 4. Efficiency of adenovirus vector infection and effect of PLZF on proliferation of cultured HCECs.  A: GFP-positive cells in cultured
HCECs 48 h after infection. HCECs at 80% confluency were infected at an MOI of 50, 100, and 200 with an adenovirus vector expressing
GFP. Phase-contrast photograph (left) and fluorescence photograph (right) showing the infection efficiency was 14% at an MOI of 50, 24% at
an MOI of 100, and 41% at an MOI of 200. B: Western blot analysis with anti-PLZF antibody of cultured HCECs infected with Ad-PLZF and
uninfected cells. HCECs at 80% confluency were infected with Ad-PLZF. The cells were harvested 48 h after infection. Lane 1: MOI 50; Lane
2: MOI 100; Lane 3: MOI 200; Lane 4: uninfected HCECs. C: The cells were harvested at 24 h after infection, and the cells were seeded into
a 16-well strip. Cell index values were determined every hour automatically by the RT-CES system for up to 72 h. Each blot is an average of
8 samples. D: Cell index values at 24 and 48 h are shown. Error bars designate standard deviations. The asterisk indicates a significant
difference (p<0.001) between Ad-PLZF and Ad-LacZ (n=8 each).
653but were formed after the 100% confluency. These results led
us to hypothesize that the PLZF expression might be related
to cell-cell contact and should be investigated in more detail.
Effect of disruption of the cell-cell contact on PLZF mRNA
expression:  To determine whether cell-cell contact is associ-
ated with the expression of the PLZF gene, confluently-cul-
tured HCECs were incubated with 3.2 mM EDTA for 2 h and
replaced with normal culture medium containing no EDTA
(Figure 3A). After the treatment, HCECs were harvested at
specific times, and the changes of the mRNA of PLZF were
assessed by real-time PCR. The results showed that the ex-
pression of the mRNA of PLZF decreased by about 20 fold at
3 h after the EDTA treatment, but began to increase at 24 h
after replacing the EDTA media with normal media. The level
of PLZF recovered to the original level when the cell-cell con-
tacts were reformed at 72 h (Figure 3B).
When the same experiment was performed on cultured
human umbilical vein endothelial cells (HUVEC), the expres-
sion of PLZF mRNA was not changed by EDTA treatment
(Figure 3C), suggesting the importance of PLZF in the cell-
cell contact of corneal endothelial cells.
Effect of PLZF gene transfer on the proliferation of cul-
tured HCECs:  To test the hypothesis that the PLZF may sup-
press the proliferation of HCECs, we first infected subconfluent
cultured HCECs with Ad-PLZF at an MOI of 50, 100, and
200. The efficiency of infection of the Ad-GFP vectors into
HCECs at 48 h was 14% at an MOI of 50, 24% at an MOI of
100, and 41% at an MOI of 200 (Figure 4A). At the same
time, western blot analysis using anti-PLZF antibody revealed
a single band of approximately 70 kDa. The intensity of the
bands was strongly correlated to the multiplicity of infection
(Figure 4B). Because PLZF mRNA was expressed at low lev-
els in the uninfected cultured HCECs, PLZF protein may be
undetectable by the western blot analysis employed in this
study.
The cell proliferation assay was done using the RT-CES
system with the Ad-LacZ cells serving as the control. When
the cell proliferation rate was continuously monitored, it was
found that infection with Ad-PLZF at an MOI of 100 inhib-
ited the cell growth by 30.3% at 24 h and 26.5% at 48 h com-
pared to that with Ad-LacZ (Figure 4D). This inhibition was
statistically significant, and the effect lasted up to 72 h (Fig-
ure 4C).
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Figure 5. The expression of mRNA of cadherin family and ZO-1.  A:
Ethidium-bromide-stained agarose gels showing PCR products for
cadherin family (40 cycles). 1: In vitro HCECs, 2: in vivo HCECs, 3:
in vitro HUVEC, 4: normal human skin. B, and C: Time course of
the expression of the N-cadherin and ZO-1 mRNA in cultured HCECs.
Cultured HCECs were collected at 40%, 60%, 80%, and 100% (1
day, 3 days, 5 days, and 7 days, respectively) after reaching
confluency. The relative expressions of N-cadherin and ZO-1 mRNA
were determined by real-time PCR, and the amount of each mRNA
was calculated relative to the amount of GAPDH mRNA in the same
sample (n=3 each). The ratio of the sample from 100%/5 day was set
to 1 for N-cadherin and 100%/3 day to 1 for ZO-1.
Figure 6. Expression of TSC-22 mRNA in cultured HCECs.  HCECs
at 50% confluency were infected with Ad-PLZF or Ad-LacZ at an
MOI of 100. The cells were harvested 48 h after infection. The rela-
tive expression of TSC-22 mRNA was determined by real-time PCR,
and the amount of each mRNA was calculated relative to the amount
of GAPDH mRNA in the same samples. The ratio of the sample
from Ad-LacZ was set to “1”. The asterisk indicates a significant
difference (p<0.005) between Ad-PLZF and Ad-LacZ (n=4 each).
654Comparison of mRNA expression of cadherin family in
cultured HCECs in vitro and normal HCECs in vivo, and ki-
netics of N-cadherin mRNA expression in primary cultured
HCEC:  The expression of five members of the human cadherin
family: E-cadherin, N-cadherin, VE-cadherin, V-cadherin, and
P-cadherin, were compared in vitro HCECs, in vivo HCECs,
in vitro HUVEC, and normal human skin by RT-PCR. N-
cadhein and V-cadherin were detected in in vitro HCECs,
whereas only N-cadherin was detected in in vivo HCECs (Fig-
ure 5A).
Next, the kinetics of the expression of the mRNA of the
N-cadherin was examined in primary cultured HCECs by real-
time PCR. In contrast to the expression of PLZF, N-cadherin
expression was detected at high levels in subconfluent HCECs,
and decreased as cultured HCECs attained confluency (Fig-
ure 5B). When the same experiment was performed on the
mRNA expression of ZO-1, no change was found in the kinet-
ics of ZO-1 mRNA expression (Figure 5C).
Determination of PLZF-induced gene expression in
HCECs:  Finally, the changes in the expression of genes in
HCECs induced by PLZF were determined by DNA
microarray analysis. When a total of 30,000 genes were ana-
lyzed, PLZF was shown to upregulate at least 54 genes and
down-regulate at least 34 genes. Unexpectedly, the expres-
sion of cyclin A2 and c-myc genes were not affected by an
over-expression of the PLZF gene in HCECs (data not shown).
Two growth factors including heparin-binding epidermal
growth factor-like growth factor (HB-EGF) and connective
tissue growth factor were the most down-regulated by 0.059
fold and 0.188 fold, respectively. Of particular interest was
the discovery that the transforming growth factor β stimulated
clone 22 (TSC-22) gene was up-regulated by 2.32 fold (data
not shown). The increased expression of the mRNA of TSC-
22 was also confirmed by real-time PCR (Figure 6).
Expression of PLZF mRNA in corneal endothelial cells
with iridocorneal endothelial syndrome (ICE syndrome):  We
have examined the expression of the mRNA of PLZF in cor-
neal endothelial cells obtained from three patients with the
ICE syndrome (Figure 7A), and found that the relative ex-
pression of the mRNA of PLZF was lower in these patients
than in normal controls by real-time PCR (Figure 7B). In par-
ticular, the expression of PLZF mRNA was undetectable in
Chandler’s syndrome (Figure 7B,C). The relative expression
of the mRNA of PLZF as normal controls is the average value
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Figure 7. Expression of the mRNA of PLZF in the corneal endothe-
lial cells from patients with the ICE syndrome.  A: 1: Chandler’s
syndrome, 2: Progressive essential iris atrophy, 3: Cogan-Reese syn-
drome. B: The relative expression of PLZF mRNA was determined
by real-time PCR, and the amount of each mRNA was calculated
relative to the amount of GAPDH mRNA in the same samples. The
ratio of the sample from progressive essential iris atrophy was set to
“1”. C. Ethidium-bromide-stained agarose gels showing PCR prod-
ucts for PLZF (40 cycles).
655of four normal human corneal endothelial cells (ages 62, 67,
73, and 73 years).
DISCUSSION
 PLZF is a transcriptional repressor and is known to suppress
the expression of several genes that regulate cell prolifera-
tion. Thus, in earlier studies, an enhanced expression of PLZF
led to the suppression of proliferation in some cell lines [11,21].
In murine 32Dcl3 cells, the cell cycling profiles of over-ex-
pressing PLZF were significantly altered, and up to 80% of
the cells accumulated in the G0/G1 phase with a significantly
smaller proportion of cells than in the S phase [21].
Our results showed that, among the different members of
the BTB/POZ-zinc finger family, PLZF was the only gene that
varied in association with the alterations of HCECs. Thus,
PLZF was not expressed in HCECs in the proliferative phase
and was later expressed when the cultured cells reached
confluency. We also found that the expression of the PLZF
mRNA was profoundly decreased when the cell-cell contact
was disrupted by EDTA treatment, and mRNA expression re-
turned to the original level as the cell-cell contact was reformed.
These changes in the expression pattern suggest that PLZF
gene expression may be regulated by cell-cell contact and re-
lated to the proliferation of HCECs. In fact, our results are
quite consistent with recent reports in which EDTA-exposed
corneal endothelial cells were released from contact inhibi-
tion and subsequently proliferated [22]. Another study has
shown that the cell-cell contact-induced inhibition is medi-
ated, at least in part, by p27kip1 because the p27kip1 protein level
is 20 times higher in confluent rat corneal endothelial cells
than in subconfluent cells. In addition, the level of the p27kip1
protein is substantially lower in EDTA-treated confluent cells
than in untreated control cells [23]. Although the link between
PLZF and p27kip1 has not been determined, both genes pre-
sumably contribute to the contact inhibition of HCECs.
The cell adhesion molecules expressed in corneal endot-
helial cells are ZO-1, connexin-43, and cadherin [24-26].
Among these, the cadherins are major intercellular adhesion
molecules that mediate calcium-dependent cell-cell adhesion
through homophilic interactions [27]. It has been demonstrated
that a breakdown in the cadherin-mediated cell adhesion acti-
vates a β-catenin-mediated intracellular signaling pathway,
inducing the expression of a set of genes, including cyclin
D1, c-myc, and c-jun, that are critical for cell proliferation
and cell survival [28-30].
We  have examined the expression of cadherin family
mRNA in cultured HCECs and in vivo HCECs, and N-cadherin
was found to be the major cadherin in HCECs. In addition,
the expression of N-cadherin increased in proliferating HCECs
before the expression of PLZF (Figure 5B). We have hypoth-
esized that N-cadherin and its downstream signaling pathways
are the candidate molecules involved in the regulation of the
expression of the PLZF gene. Currently, experiments are be-
ing carried out in our laboratory to test this hypothesis.
The involvement of PLZF in suppressing the prolifera-
tion of cultured HCECs has been clearly demonstrated by in-
fection of the PLZF gene in HCECs. The degree of the sup-
pression was not as high as in murine 32Dcl3 cells, but con-
sidering an infection efficiency of 24% at an MOI of 100 with
the Ad-GFP vector, an over-expression of PLZF led to a rela-
tively high degree of suppression of the proliferation of
HCECs. In addition, TSC-22 was found to be increased in
HCECs which over-expressed the PLZF gene according to
the DNA microarray analysis. TSC-22, a leucine zipper tran-
scriptional factor, was found to be an immediate-early target
gene of TGFβ1 [31] and has the characteristics of a suppressor
of cell proliferation [32-34]. Moreover, TSC-22 binds to and
modulates the transcriptional activity of Smad3 and Smad4,
and it enhances TGFβ signaling by associating with Smad4
[35]. Evidence has been showing that TGFβ2 is present in high
concentrations in normal aqueous humor [36,37], and it sup-
presses the proliferation of rabbit and rat corneal endothelial
cells in vitro [7,38,39]. Thus, TSC-22 might be involved as a
target gene for PLZF in suppressing HCEC proliferation in
accordance with TGFβ signaling pathway. This hypothesis,
however, needs further investigation.
We have also examined the expression of PLZF mRNA
in the corneal endothelial cells obtained from three patients
with iridocorneal endothelial syndrome (ICE syndrome). In-
terestingly, the relative expression of the mRNA of PLZF in
ICE syndrome was lower than in normal controls by real-time
PCR. In particular, the expression of PLZF mRNA was unde-
tectable in Chandler’s syndrome (Figure 7). These findings
suggest that the absence of the PLZF gene may lead to the
abnormal proliferation of corneal endothelial cells, a hallmark
of the ICE syndrome.
In conclusion, we have shown that the mRNA of PLZF
was closely associated with cell-cell contact phenomenon of
human corneal endothelial cells. Further studies are needed to
clarify the correlation of the PLZF gene with the intracellular
signals governed by TGF-beta and with the expression of the
cell adhesion molecule such as cadherin. As PLZF is normally
expressed in the human corneal endothelium, it can serve as a
possible target to modulate cell proliferation. It may be pos-
sible in the future to treat patients with severe corneal endot-
helial damage if the key factor regulating the expression of
the PLZF gene and the genes regulated by PLZF are identi-
fied.
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